Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00041353

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Breast Cancer Biomarkers Based on Fine Needle Aspirates

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Fox Chase Cancer Center · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Examining biomarkers in fine-needle aspiration specimens from women at risk for breast cancer may improve the ability to detect breast cancer cells early and plan effective treatment. PURPOSE: Screening trial to compare specific biomarkers based on fine-needle aspiration specimens from women at increased or normal risk of breast cancer.

Detailed description

OBJECTIVES: * Compare specific biomarkers, including cellular morphology (cytology), proliferation index (Ki-67), p53 expression, and LOH in chromosome 9p at locus DS9157, in fine needle aspirate specimens from women at increased vs normal risk of breast cancer. * Determine whether these specimens are adequate to perform the biomarker assays and whether this technique could be used in the general outpatient setting. * Determine whether biomarker levels in these patients are concordant or discordant with individual clinical risk of breast cancer. * Determine whether 1 or more biomarkers can distinguish high-risk from control patients. * Correlate specific biomarkers and changes in biomarker levels with pathologic diagnosis from the breast biopsy. OUTLINE: Patients undergo fine needle aspiration of normal appearing breast tissue prior to the beginning of elective surgery. Specimens are analyzed for the presence of specific biomarkers. PROJECTED ACCRUAL: Approximately 156 patients will be accrued for this study within 3 years.

Conditions

Interventions

TypeNameDescription
OTHERcytology specimen collection procedure
PROCEDUREcomparison of screening methods
PROCEDUREstudy of high risk factors

Timeline

Primary completion
2002-09-01
Completion
2002-09-01
First posted
2003-05-26
Last updated
2013-07-11

Source: ClinicalTrials.gov record NCT00041353. Inclusion in this directory is not an endorsement.